title: Pro- and anti-fibrotic effects of TGF-beta in scleroderma.
abstract: The University of California at Davis 200 and 206 (UCD-200/206) lines of chickens have proven to be the animal model that best reflects the situation in human SSc. We have demonstrated a misbalance of pro-fibrotic (TGF-beta1) and anti-fibrotic (TGF-beta2 and -beta3) TGF-beta isoforms as a possible cause for fibrotic alterations in this model. This opens new avenues for diagnosis and therapy for this still intractable condition.
authors.affiliation: Division of Experimental Pathophysiology and Immunology, Laboratory of Autoimmunity, Biocenter, Medical University of Innsbruck, Peter-Mayr-Strasse 4a, A-6020 Innsbruck, Austria.
authors.forename: R
authors.initials: R
authors.lastname: Sgonc
authors.forename: G
authors.initials: G
authors.lastname: Wick
mesh_terms: D000818:Animals; D002645:Chickens; D005355:Fibrosis; D023421:Models, Animal; D012595:Scleroderma, Systemic / Q000378:metabolism* / Q000473:pathology; D012867:Skin / Q000378:metabolism* / Q000473:pathology; D016212:Transforming Growth Factor beta / Q000502:physiology*
chemical_list: D016212:Transforming Growth Factor beta
references.citation: Nat Clin Pract Rheumatol. 2006 Mar;2(3):134-44
references.pmid: 16932673
references.citation: J Autoimmun. 1995 Oct;8(5):763-70
references.pmid: 8579730
references.citation: Mol Med. 1997 Oct;3(10):654-62
references.pmid: 9392002
references.citation: Adv Immunol. 2006;92:71-117
references.pmid: 17145302
references.citation: Arthritis Res Ther. 2006;8(4):213
references.pmid: 16774692
references.citation: N Engl J Med. 2000 May 4;342(18):1350-8
references.pmid: 10793168
references.citation: J Clin Invest. 1996 Aug 1;98(3):785-92
references.pmid: 8698871
references.citation: J Autoimmun. 1992 Oct;5(5):603-15
references.pmid: 1418297
references.citation: Arthritis Rheum. 2007 Jan;56(1):323-33
references.pmid: 17195236
references.citation: Arthritis Rheum. 2005 Jun;52(6):1804-11
references.pmid: 15934083